L-Selectin is a possible biomarker for individual PML risk...

Neurology 2013 / 09 Vol. 81; Iss. 10

L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients

Schwab, N., Schneider-Hohendorf, T., Posevitz, V., Breuer, J., Gobel, K., Windhagen, S., Brochet, B., Vermersch, P., Lebrun-Frenay, C., Posevitz-Fejfar, A., Capra, R., Imberti, L., Straeten, V., Haas,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
81
Language:
english
Journal:
Neurology
DOI:
10.1212/WNL.0b013e3182a351fb
Date:
September, 2013
File:
PDF, 724 KB
english, 2013
Conversion to is in progress
Conversion to is failed